FibroGen, Inc.FGENNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +15.45% | -554.18% | -89.20% | +35.07% | -97.68% |
| Gross Profit Growth | +14.34% | -572.09% | +0.00% | +0.00% | -97.24% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -95.91% | -95.91% | +1.99% | +1.23% | +0.58% |
| Weighted Average Shares Diluted Growth | -95.91% | -95.91% | +1.99% | +1.23% | +0.58% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +162.93% | -98.83% | -99.78% | -99.61% | -99.85% |
| Inventory Growth | -41.18% | -92.41% | -88.46% | -84.79% | -83.86% |
| Asset Growth | -42.57% | -49.35% | -54.84% | -39.27% | -48.18% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -48.34% | -47.10% | -60.06% | -49.63% | -75.46% |
| R&D Expense Growth | -64.53% | -97.13% | -74.86% | -81.88% | -94.43% |
| SG&A Expenses Growth | -31.36% | -154.99% | +0.00% | +0.00% | -69.84% |